This proposed rule focuses primarily on PMTA evaluate treatments and material necessities, specially with respect to application acceptance and submitting. An software may well meet the acceptance and submitting requirements, but still lack crucial data that FDA requires to find out no matter if it must difficulty a advertising order. The proposed